The highly anticipated Aesthetics Media webinar, titled Azzalure (abobotulinum toxin type A) in Action: Key Principles and Treatment for Glabellar Lines in association with pharmaceutical company Galderma UK, is taking place on June 17 from 7pm. It will last approximately one hour.
Professor Syed Haq will present on the key principles and science behind toxins, detailing what different toxins are on the market, their field of effect, safety and efficacy as well the key questions that aesthetic practitioners should be asking when purchasing a toxin.
Aesthetic nurse prescriber Lou Sommereux will then discuss the treatment of the glabellar lines specifically. She will explore the anatomy, reference points for injections, share best practice and provide advice on minimising risks. This will then be supported with several live treatment demonstrations on an older female, younger female and a male patient.
Professor Haq commented, “From this webinar I believe that attendees will learn exactly how important it is for us as practitioners to understand the product that you are using and the background behind it. It’s an educational forum and will reinforce what you need to understand to maintain good clinical practice.”
The Azzalure (abobotulinum toxin type A) in Action: Key Principles & Treatment for Glabellar Lines webinar is only available for doctors, surgeons, nurses and dentists with a valid professional licence. You must submit your licence (GMC/NMC/GDC certificate) and proof of identity certificates (e.g. driving licence/passport) to DocCheck by June 13 by clicking here.
We look forward to sharing the webinar with you in June. If you have any questions, please contact Aesthetic Media:
P: 0203 096 1228
This webinar is supported by Galderma. Full prescribing information for Azzalure (abobotulinum toxin type A) can be found here.